Health Costs

COSTS and Affordability

KFF Health Tracking Poll: Health Care Costs and the Midterms

This KFF poll finds that health care costs continue to top the public’s list of affordability worries, even as concerns about gas prices have risen in recent weeks, with two-thirds of the public expressing worry over affording health care costs. Majorities say health costs will influence their vote this election. Voters favor Democrats on the issue, while Republicans hold an advantage on addressing fraud and abuse.

Affordable care act

ACA Marketplace Survey Feature Image - Website

Cost Concerns and Coverage Changes: A Follow-Up Survey of ACA Marketplace Enrollees

This KFF survey is a follow-up survey of adults who had ACA Marketplace insurance in 2025. The survey examines the cost concerns and coverage changes of Marketplace enrollees following the end of the enhanced premium tax credits and finds that half of returning enrollees say their health care costs are “a lot higher” and most expect to cut back on basic household expenses to afford coverage.

Health System Tracker

What Are the Recent Trends in Employer-Based Health Coverage? Employer-sponsored health insurance is the largest source of health coverage for people under 65, but its reach is uneven.

How Does U.S. Life Expectancy Compare to Other Countries? The life expectancy gap between the U.S. and peer countries decreased from 4.1 years in 2023 to 3.7 years in 2024 as U.S. mortality dropped.

How Does Cost Affect Access to Health Care? In 2024, about 1 in 6 adults reported delaying or not getting healthcare due to cost, including medical or mental health care.

How Does Health Spending in the U.S. Compare to Other Countries? While the U.S. still spends the most in total dollars, eight OECD nations had a higher percentage increase in per-person health spending in 2024.

Latest News

No Posts to Show

Filter

951 - 960 of 1,577 Results

  • The Role of Independent Commissions in Controlling Costs and Enhancing Value: International Lessons

    Event Date:
    Event

    The Alliance for Health Reform and the Commonwealth Fund co-sponsored this briefing to examine the quasi-governmental authorities that Germany, the Netherlands and France have established to control health care costs, oversee quality, and regulate insurance and provider payment. How and why have these quasi-governmental authorities come into being? What is their scope of power, and the mechanism they provide for bringing stakeholders together in health care decision making? What are the respective roles of government…

  • Summary of Coverage Provisions in the Patient Protection and Affordable Care Act

    Issue Brief

    This short summary describes the health coverage provisions contained in the final version of the Affordable Care Act signed into law in March 2010, including the individual mandate requirements, expansion of public programs, health insurance exchanges, changes to private insurance and employer requirements.

  • Health Affairs Article: The Growth In Cost Per Case Explains Far More Of US Health Spending Increases Than Rising Disease Prevalence

    Report

    Health Affairs Article: The Growth In Cost Per Case Explains Far More Of U.S. Health Spending Increases Than Rising Disease Prevalence This article examines national health spending across an all-inclusive set of diagnostic categories and medical conditions between 1996 and 2006, focusing on trends in cost of care per case and treated prevalence—or, the number of people receiving treatment for a particular condition. It also presents initial estimates of the impact of clinical prevalence on…

  • National Survey of Small Businesses

    Other Post

    Survey highlights/chartpack from a new survey that finds that two-thirds of small employers say that they are dissatisfied with the cost of health care and health insurance, and about one-third of small businesses that now offer insurance say they are likely to increase the share of costs borne by employees in the next year. Survey Highlights and Chart Pack

  • Federal Policies Affecting The Cost and Availability of New Pharmaceuticals

    Report

    This report by Michael Gluck of the Georgetown University Institute for Health Care Research and Policy examines several ways in which the federal government influences the availability and cost of prescription drugs, including 1) intellectual property protection the laws and policies which regulate and influence patents and generic competition (include the Hatch-Waxman Act), 2) federal support for drug research and development, 3) federal tax subsidies through various tax credits available to pharmaceutical firms, and 4)…

  • The Sad History of Cost Containment as Told in One Chart

    Other Post

    As the nation once again faces double digit increases in health care costs, the seemingly unanswerable question of how to control the problem has suddenly returned to the nation's radar screen. This analysis by the Kaiser Family Foundation, published in the January 23, 2002 online version of the journal Health Affairs (under Web Exclusives) traces the effectiveness of government and private sector attempts to reign in health care costs over the past three decades and…

  • The Role of National Firms in Medicare+Choice

    Report

    This report addresses national managed care firms participation in M+C and the factors influencing their decision processes about M+C products. Based on interviews with executives and senior staff of national managed care firms, this report examines how eight national firms strategically position their M+C product, including the process that firms use when making decisions and the key factors they say most influence their decisions related to participation. Report

  • Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001Data Update

    Report

    Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001 Data Update This data update provides estimates of supplemental insurance and prescription drug coverage rates and trends between 1996 and 2001, which will help to provide important context for assessing future changes in supplemental insurance and drug coverage rates after provisions of the Medicare drug benefit take effect. Report (.pdf)

  • Section 4: Health Insurance Choice

    Report

    Exhibit 4.1 Exhibit 4.6 Exhibit 4.2 Exhibit 4.7 Exhibit 4.3 Exhibit 4.8 Exhibit 4.4 Exhibit 4.9 Exhibit 4.5 Exhibit 4.10 5Survey respondents were asked whether the firm offers a personal or health savings account, including a Health Reimbursement Arrangement (HRA) or other type of health savings account option. 6There are several savings account options permitted under the law, including health reimbursement arrangements, health savings accounts and medical savings accounts. 7Due to the low number of…